Protein Characterization and Identification Market Size to Hit USD 8.04 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Protein Characterization and Identification Market

5.1. COVID-19 Landscape: Protein Characterization and Identification Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Protein Characterization and Identification Market, By Product/Offering

8.1. Protein Characterization and Identification Market, by Product/Offering

8.1.1. Instruments and Systems

8.1.1.1. Market Revenue and Forecast

8.1.2. Consumables and Reagents (kits, columns, standards)

8.1.2.1. Market Revenue and Forecast

8.1.3. Software and Informatics (analysis, spectral libraries, LIMS)

8.1.3.1. Market Revenue and Forecast

8.1.4. Services (outsourced proteomics, method development, contract testing)

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Protein Characterization and Identification Market, By Technology/Method

9.1. Protein Characterization and Identification Market, by Technology/Method

9.1.1. Mass Spectrometry (LC-MS/MS, MALDI-TOF, HR-MS)

9.1.1.1. Market Revenue and Forecast

9.1.2. Chromatography (HPLC/UPLC, SEC, ion-exchange, affinity)

9.1.2.1. Market Revenue and Forecast

9.1.3. Electrophoresis and Western/Blotting (SDS-PAGE, 2D, capillary)

9.1.3.1. Market Revenue and Forecast

9.1.4. Spectroscopy (CD, FTIR, UV-Vis)

9.1.4.1. Market Revenue and Forecast

9.1.5. Biophysical and Interaction Analysis (SPR, BLI, ITC, MST)

9.1.5.1. Market Revenue and Forecast

9.1.6. Structural/High-resolution (Cryo-EM, X-ray crystallography — typically outsourced/high-capex)

9.1.6.1. Market Revenue and Forecast

9.1.7. Immunoassays (ELISA, multiplex assays)

9.1.7.1. Market Revenue and Forecast

Chapter 10. Global Protein Characterization and Identification Market, By Workflow Stage/Use Case

10.1. Protein Characterization and Identification Market, by Workflow Stage/Use Case

10.1.1. Protein identification and sequencing

10.1.1.1. Market Revenue and Forecast

10.1.2. PTM analysis and mapping

10.1.2.1. Market Revenue and Forecast

10.1.3. Quantitation (absolute/relative proteomics)

10.1.3.1. Market Revenue and Forecast

10.1.4. Structural conformation and stability testing

10.1.4.1. Market Revenue and Forecast

10.1.5. Interaction mapping and kinetics

10.1.5.1. Market Revenue and Forecast

10.1.6. Purity and impurity profiling (including aggregates)

10.1.6.1. Market Revenue and Forecast

Chapter 11. Global Protein Characterization and Identification Market, By Sample Type

11.1. Protein Characterization and Identification Market, by Sample Type

11.1.1. Recombinant/biotherapeutic proteins (mAbs, ADCs)

11.1.1.1. Market Revenue and Forecast

11.1.2. Cell lysates and complex proteomes

11.1.2.1. Market Revenue and Forecast

11.1.3. Plasma/serum and clinical samples

11.1.3.1. Market Revenue and Forecast

11.1.4. Tissue samples and biopsies

11.1.4.1. Market Revenue and Forecast

11.1.5. Food and agricultural samples

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Protein Characterization and Identification Market, By End-User/Vertical

12.1. Protein Characterization and Identification Market, by End-User/Vertical

12.1.1. Biopharmaceutical and CROs (drug discovery, biologics development)

12.1.1.1. Market Revenue and Forecast

12.1.2. Academic and government research institutes

12.1.2.1. Market Revenue and Forecast

12.1.3. Clinical and diagnostic laboratories

12.1.3.1. Market Revenue and Forecast

12.1.4. Contract testing and proteomics service providers

12.1.4.1. Market Revenue and Forecast

12.1.5. Food and beverage/agriculture

12.1.5.1. Market Revenue and Forecast

12.1.6. Industrial biotech and manufacturing QA/QC

12.1.6.1. Market Revenue and Forecast

Chapter 13. Global Protein Characterization and Identification Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product/Offering

13.1.2. Market Revenue and Forecast, by Technology/Method

13.1.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.1.4. Market Revenue and Forecast, by Sample Type

13.1.5. Market Revenue and Forecast, by End-User/Vertical

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product/Offering

13.1.6.2. Market Revenue and Forecast, by Technology/Method

13.1.6.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.1.6.4. Market Revenue and Forecast, by Sample Type

13.1.6.5. Market Revenue and Forecast, by End-User/Vertical

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product/Offering

13.1.7.2. Market Revenue and Forecast, by Technology/Method

13.1.7.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.1.7.4. Market Revenue and Forecast, by Sample Type

13.1.7.5. Market Revenue and Forecast, by End-User/Vertical

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product/Offering

13.2.2. Market Revenue and Forecast, by Technology/Method

13.2.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.2.4. Market Revenue and Forecast, by Sample Type

13.2.5. Market Revenue and Forecast, by End-User/Vertical

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product/Offering

13.2.6.2. Market Revenue and Forecast, by Technology/Method

13.2.6.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.2.7. Market Revenue and Forecast, by Sample Type

13.2.8. Market Revenue and Forecast, by End-User/Vertical

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product/Offering

13.2.9.2. Market Revenue and Forecast, by Technology/Method

13.2.9.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.2.10. Market Revenue and Forecast, by Sample Type

13.2.11. Market Revenue and Forecast, by End-User/Vertical

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product/Offering

13.2.12.2. Market Revenue and Forecast, by Technology/Method

13.2.12.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.2.12.4. Market Revenue and Forecast, by Sample Type

13.2.13. Market Revenue and Forecast, by End-User/Vertical

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product/Offering

13.2.14.2. Market Revenue and Forecast, by Technology/Method

13.2.14.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.2.14.4. Market Revenue and Forecast, by Sample Type

13.2.15. Market Revenue and Forecast, by End-User/Vertical

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product/Offering

13.3.2. Market Revenue and Forecast, by Technology/Method

13.3.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.3.4. Market Revenue and Forecast, by Sample Type

13.3.5. Market Revenue and Forecast, by End-User/Vertical

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product/Offering

13.3.6.2. Market Revenue and Forecast, by Technology/Method

13.3.6.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.3.6.4. Market Revenue and Forecast, by Sample Type

13.3.7. Market Revenue and Forecast, by End-User/Vertical

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product/Offering

13.3.8.2. Market Revenue and Forecast, by Technology/Method

13.3.8.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.3.8.4. Market Revenue and Forecast, by Sample Type

13.3.9. Market Revenue and Forecast, by End-User/Vertical

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product/Offering

13.3.10.2. Market Revenue and Forecast, by Technology/Method

13.3.10.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.3.10.4. Market Revenue and Forecast, by Sample Type

13.3.10.5. Market Revenue and Forecast, by End-User/Vertical

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product/Offering

13.3.11.2. Market Revenue and Forecast, by Technology/Method

13.3.11.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.3.11.4. Market Revenue and Forecast, by Sample Type

13.3.11.5. Market Revenue and Forecast, by End-User/Vertical

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product/Offering

13.4.2. Market Revenue and Forecast, by Technology/Method

13.4.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.4.4. Market Revenue and Forecast, by Sample Type

13.4.5. Market Revenue and Forecast, by End-User/Vertical

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product/Offering

13.4.6.2. Market Revenue and Forecast, by Technology/Method

13.4.6.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.4.6.4. Market Revenue and Forecast, by Sample Type

13.4.7. Market Revenue and Forecast, by End-User/Vertical

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product/Offering

13.4.8.2. Market Revenue and Forecast, by Technology/Method

13.4.8.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.4.8.4. Market Revenue and Forecast, by Sample Type

13.4.9. Market Revenue and Forecast, by End-User/Vertical

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product/Offering

13.4.10.2. Market Revenue and Forecast, by Technology/Method

13.4.10.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.4.10.4. Market Revenue and Forecast, by Sample Type

13.4.10.5. Market Revenue and Forecast, by End-User/Vertical

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product/Offering

13.4.11.2. Market Revenue and Forecast, by Technology/Method

13.4.11.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.4.11.4. Market Revenue and Forecast, by Sample Type

13.4.11.5. Market Revenue and Forecast, by End-User/Vertical

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product/Offering

13.5.2. Market Revenue and Forecast, by Technology/Method

13.5.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.5.4. Market Revenue and Forecast, by Sample Type

13.5.5. Market Revenue and Forecast, by End-User/Vertical

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product/Offering

13.5.6.2. Market Revenue and Forecast, by Technology/Method

13.5.6.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.5.6.4. Market Revenue and Forecast, by Sample Type

13.5.7. Market Revenue and Forecast, by End-User/Vertical

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product/Offering

13.5.8.2. Market Revenue and Forecast, by Technology/Method

13.5.8.3. Market Revenue and Forecast, by Workflow Stage/Use Case

13.5.8.4. Market Revenue and Forecast, by Sample Type

13.5.8.5. Market Revenue and Forecast, by End-User/Vertical

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Agilent Technologies

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Waters Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Bruker Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. SCIEX (Danaher group)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Shimadzu Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Merck KGaA/MilliporeSigma

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Bio-Rad Laboratories

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. PerkinElmer, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Cytiva (GE Life Sciences alumni)

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The protein characterization and identification market size is expected to increase from USD 4.80 billion in 2024 to USD 8.04 billion by 2034.

The protein characterization and identification market is expected to grow at a compound annual growth rate (CAGR) of around 5.29% from 2025 to 2034.

The major players in the protein characterization and identification market include Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bruker Corporation, SCIEX (Danaher group), Shimadzu Corporation, Merck KGaA/MilliporeSigma, Bio-Rad Laboratories, PerkinElmer, Inc., Cytiva (GE Life Sciences alumni), Promega Corporation, Bio-Techne Corporation, Eurofins Scientific (proteomics and testing services), Charles River Laboratories (analytical and bioanalytical services), and NanoTemper Technologies.

The driving factors of the protein characterization and identification market are the increasing demand for advanced analytical techniques in drug development, biotechnology research, and quality control across pharmaceuticals and life sciences.

North America region will lead the global protein characterization and identification market during the forecast period 2025 to 2034.